Oxaliplatin is primarily used to treat stage III colon cancer after surgery and advanced colorectal cancer in combination with 5-fluorouracil (5-FU) and leucovorin (LV). It is also used in the treatment of metastatic pancreatic cancer, mantle cell lymphoma, and non-Hodgkin’s lymphoma as part of combination therapy. By working together with other anticancer medications, oxaliplatin helps control cancer growth and reduce disease progression.

Oxaliplatin works by damaging the DNA of cancer cells. It forms cross-links within DNA strands, preventing cancer cells from dividing and multiplying. Since rapidly growing cancer cells rely heavily on DNA replication, the medication interferes with their growth and eventually leads to cell death. This mechanism helps slow tumor progression and improve treatment response.

Oxaliplatin is administered intravenously through a vein under the supervision of a healthcare professional. It is usually given in combination with leucovorin and fluorouracil as part of a treatment cycle repeated every two weeks. On the first treatment day, oxaliplatin and leucovorin are infused over approximately two hours, followed by fluorouracil administration. Treatment schedules and dosages are determined based on the patient’s body weight, height, health condition, and response to therapy. Anti-nausea medications may also be provided before treatment to reduce side effects.

Common side effects of oxaliplatin include nausea, vomiting, diarrhea, tiredness, fever, decreased blood cell counts, breathing difficulties, tingling or numbness in the hands and feet, and nerve sensitivity triggered by cold temperatures. Some patients may also experience depression, insomnia, weight loss, visual problems, blood clots, or high blood pressure. Serious side effects include allergic reactions, severe nerve damage, lung problems, and significant blood count reductions. Patients should contact their healthcare provider immediately if they experience chest tightness, severe breathing difficulty, swelling, or persistent numbness.

Oxaliplatin should be used cautiously in patients with kidney disease, liver problems, lung conditions, heart disease, or previous allergic reactions to platinum-based medications. Exposure to cold temperatures should be avoided during treatment because the medication can increase cold sensitivity and worsen nerve damage. Patients are advised to avoid cold drinks, ice, and cold environments. Regular blood tests are necessary to monitor blood cell counts and organ function. Oxaliplatin is not recommended during pregnancy or breastfeeding due to potential harm to the baby. Patients should inform their doctor about all medications, supplements, or herbal products they are taking before starting treatment.

Oxaliplatin has become an essential chemotherapy medication in the treatment of colorectal cancer and several other cancers. Its ability to work effectively in combination with other anticancer drugs has improved treatment outcomes for many patients. However, proper monitoring, adherence to medical advice, and precautions against cold exposure are important for managing side effects and maintaining quality of life during therapy. With careful supervision, oxaliplatin continues to play a valuable role in modern cancer treatment.